News
The U.S. Food and Drug Administration (FDA) has announced the official launch of Elsa, a cutting-edge generative Artificial ...
Shares of Hims & Hers have crushed the market over the last year. When it comes to stocks that continue to beat the market, my guess is that your mind goes straight to companies leading the charge in ...
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
A British High Court judge says lawyers have cited fake cases generated by artificial intelligence in court proceedings in ...
TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...
Legislative-imposed reallocation plans position Utah schools for the future — while exacting weighty price in layoffs, ...
QBurst is expanding its ability to make AI a key part of its application development capabilities, CEO Arun Kumar “Rak” ...
Safety Management Systems (SMS), once fragmented and largely dependent on airline-specific manuals, are now maturing into ...
The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based ...
The faulty tool, created by a staffer with no medical or government experience, helped accelerate the gutting of the VA.
The National Institutes of Health is seeking comment from industry on a new artificial intelligence strategy for the agency. ...
In the latest episode of Your Next Move, produced by Inc. and Capital One Business, health care company founders share five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results